gsk 835726
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2007 (NCT00605852)
Timeline
Indications
Studied for
Mechanism of action
- Histamine H3 receptorINHIBITOR
HRH3 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gsk835726
- gsk835726
- gsk835726
- gsk 835726
- gsk-835726
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00972504 | Phase 2 | Jun 1, 2009 | GlaxoSmithKline |
| NCT00851344 | Phase 2 | Sep 1, 2008 | GlaxoSmithKline |
| NCT00605852 | Phase 1 | Oct 1, 2007 | GlaxoSmithKline |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GlaxoSmithKline | For profit | 3 | 3 | 2 | 2007 |
1 organizations
Page 1 / 1